Generic Medicines: Old wine in new bottle?

Generic Medicines: Old wine in new bottle?

Generic medicines are cheap but effective alternative for improving access to life saving medicines in a country like India. Increasing challenge is being faced by the Indian generic industry because of gradual stricter regulatory requirements. In the process, generic medicines add cost. Increasing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of young pharmacists 2015-07, Vol.7 (3), p.143-144
Hauptverfasser: Swain, Trupti Rekha, Giri, Prajna Paramita
Format: Artikel
Sprache:eng
Schlagworte:
Generic drugs
Pharmaceutical industry
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 144
container_issue 3
container_start_page 143
container_title Journal of young pharmacists
container_volume 7
creator Swain, Trupti Rekha
Giri, Prajna Paramita
description Generic medicines are cheap but effective alternative for improving access to life saving medicines in a country like India. Increasing challenge is being faced by the Indian generic industry because of gradual stricter regulatory requirements. In the process, generic medicines add cost. Increasing costs for maintaining quality assurance, anti-counterfeit steps are also challenges the generic industry is facing now. Some originator companies tactfully mislead the physician and public that generic medicines may be less safe and effective than their branded counterpart. Mass sensitisation regarding the generics, educational efforts and better communication among patients and health care professionals, are seen as major drivers to enhance confidence on generic medicines among consumers.
doi_str_mv 10.5530/jyp.2015.3.2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1797306749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4090637811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c258t-ac48a33e691e01d22400ad4cac0d649030a93ba11b764e760b93255fa26c96303</originalsourceid><addsrcrecordid>eNo1kE1Lw0AYhBdRsNTe_AEBb2Liu_vuR9aLSKlVqPSi52Wz2UBCTOJuSum_N6E6l5nDMAMPIbcUMiEQHpvTkDGgIsOMXZAFaCVSKkBc_mee4zVZxdjALAUK9YLcb33nQ-2SD1_Wru58fEr2bZkcp5jUXdL5Y1L049j65xtyVdk2-tWfL8nX6-Zz_Zbu9tv39csudUzkY2odzy2il5p6oCVjHMCW3FkHpeQaEKzGwlJaKMm9klBoZEJUlkmnJQIuyd15dwj9z8HH0TT9IXTTpaFKKwSpuJ5aD-eWC32MwVdmCPW3DSdDwcxAzATEzEAMGoa_oW1QYQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1797306749</pqid></control><display><type>article</type><title>Generic Medicines: Old wine in new bottle?</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Swain, Trupti Rekha ; Giri, Prajna Paramita</creator><creatorcontrib>Swain, Trupti Rekha ; Giri, Prajna Paramita</creatorcontrib><description>Generic medicines are cheap but effective alternative for improving access to life saving medicines in a country like India. Increasing challenge is being faced by the Indian generic industry because of gradual stricter regulatory requirements. In the process, generic medicines add cost. Increasing costs for maintaining quality assurance, anti-counterfeit steps are also challenges the generic industry is facing now. Some originator companies tactfully mislead the physician and public that generic medicines may be less safe and effective than their branded counterpart. Mass sensitisation regarding the generics, educational efforts and better communication among patients and health care professionals, are seen as major drivers to enhance confidence on generic medicines among consumers.</description><identifier>ISSN: 0975-1483</identifier><identifier>EISSN: 0975-1505</identifier><identifier>DOI: 10.5530/jyp.2015.3.2</identifier><language>eng</language><publisher>Bangalore: InPharm</publisher><subject>Generic drugs ; Pharmaceutical industry</subject><ispartof>Journal of young pharmacists, 2015-07, Vol.7 (3), p.143-144</ispartof><rights>Copyright InPharm Jul-Sep 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Swain, Trupti Rekha</creatorcontrib><creatorcontrib>Giri, Prajna Paramita</creatorcontrib><title>Generic Medicines: Old wine in new bottle?</title><title>Journal of young pharmacists</title><description>Generic medicines are cheap but effective alternative for improving access to life saving medicines in a country like India. Increasing challenge is being faced by the Indian generic industry because of gradual stricter regulatory requirements. In the process, generic medicines add cost. Increasing costs for maintaining quality assurance, anti-counterfeit steps are also challenges the generic industry is facing now. Some originator companies tactfully mislead the physician and public that generic medicines may be less safe and effective than their branded counterpart. Mass sensitisation regarding the generics, educational efforts and better communication among patients and health care professionals, are seen as major drivers to enhance confidence on generic medicines among consumers.</description><subject>Generic drugs</subject><subject>Pharmaceutical industry</subject><issn>0975-1483</issn><issn>0975-1505</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNo1kE1Lw0AYhBdRsNTe_AEBb2Liu_vuR9aLSKlVqPSi52Wz2UBCTOJuSum_N6E6l5nDMAMPIbcUMiEQHpvTkDGgIsOMXZAFaCVSKkBc_mee4zVZxdjALAUK9YLcb33nQ-2SD1_Wru58fEr2bZkcp5jUXdL5Y1L049j65xtyVdk2-tWfL8nX6-Zz_Zbu9tv39csudUzkY2odzy2il5p6oCVjHMCW3FkHpeQaEKzGwlJaKMm9klBoZEJUlkmnJQIuyd15dwj9z8HH0TT9IXTTpaFKKwSpuJ5aD-eWC32MwVdmCPW3DSdDwcxAzATEzEAMGoa_oW1QYQ</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Swain, Trupti Rekha</creator><creator>Giri, Prajna Paramita</creator><general>InPharm</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>KB0</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20150701</creationdate><title>Generic Medicines: Old wine in new bottle?</title><author>Swain, Trupti Rekha ; Giri, Prajna Paramita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c258t-ac48a33e691e01d22400ad4cac0d649030a93ba11b764e760b93255fa26c96303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Generic drugs</topic><topic>Pharmaceutical industry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swain, Trupti Rekha</creatorcontrib><creatorcontrib>Giri, Prajna Paramita</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of young pharmacists</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swain, Trupti Rekha</au><au>Giri, Prajna Paramita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Generic Medicines: Old wine in new bottle?</atitle><jtitle>Journal of young pharmacists</jtitle><date>2015-07-01</date><risdate>2015</risdate><volume>7</volume><issue>3</issue><spage>143</spage><epage>144</epage><pages>143-144</pages><issn>0975-1483</issn><eissn>0975-1505</eissn><abstract>Generic medicines are cheap but effective alternative for improving access to life saving medicines in a country like India. Increasing challenge is being faced by the Indian generic industry because of gradual stricter regulatory requirements. In the process, generic medicines add cost. Increasing costs for maintaining quality assurance, anti-counterfeit steps are also challenges the generic industry is facing now. Some originator companies tactfully mislead the physician and public that generic medicines may be less safe and effective than their branded counterpart. Mass sensitisation regarding the generics, educational efforts and better communication among patients and health care professionals, are seen as major drivers to enhance confidence on generic medicines among consumers.</abstract><cop>Bangalore</cop><pub>InPharm</pub><doi>10.5530/jyp.2015.3.2</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0975-1483
ispartof Journal of young pharmacists, 2015-07, Vol.7 (3), p.143-144
issn 0975-1483
0975-1505
language eng
recordid cdi_proquest_journals_1797306749
source EZB-FREE-00999 freely available EZB journals
subjects Generic drugs
Pharmaceutical industry
title Generic Medicines: Old wine in new bottle?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A47%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Generic%20Medicines:%20Old%20wine%20in%20new%20bottle?&rft.jtitle=Journal%20of%20young%20pharmacists&rft.au=Swain,%20Trupti%20Rekha&rft.date=2015-07-01&rft.volume=7&rft.issue=3&rft.spage=143&rft.epage=144&rft.pages=143-144&rft.issn=0975-1483&rft.eissn=0975-1505&rft_id=info:doi/10.5530/jyp.2015.3.2&rft_dat=%3Cproquest_cross%3E4090637811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1797306749&rft_id=info:pmid/&rfr_iscdi=true